Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.AWH · Entity 7871 | Chief Executive Officer | May 22, 2025 | May 27, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date May 22, 2025 · Filed May 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.07 · Expires 2035-05-22 | Direct | 100,000 |
Reported balance
After 2025-05-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-05-22 · Grant · Acquired 100,000 · Balance 100,000 F1: The employee stock option will vest in forty-eight equal monthly amounts beginning January 30, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The employee stock option will vest in forty-eight equal monthly amounts beginning January 30, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2025 Filed May 27, 2025 10:37 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantStock Options (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.07 | $0.00 |
DisclosureSEC source: 0001641172-25-012386 · ownership.xml · derivative · entry 1 Buhle Michael William · CIK 0002061539 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-05-22 F1 · derivative.exercise_date: The employee stock option will vest in forty-eight equal monthly amounts beginning January 30, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.